TrialBritish journal of cancer2026
Safety and efficacy of lapatinib, binimetinib, and vinorelbine for RAS mutant metastatic colorectal cancer: results of the RASTRIC Phase I/II trial.
Maarten A Huismans et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.